SCHEMBL30937632

SCHEMBL30937632

COc1nccc2c1CN(CC(=O)O)C(=O)N2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACE P12821 1/20 0.40
▸ MMP13 P45452 1/20 0.40
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ DDB1 Q16531 1/20 0.32
▸ CRBN Q96SW2 1/20 0.32
▸ SLC13A5 Q86YT5 1/20 0.32
▸ ITGB3 P05106 1/20 0.31
▸ ITGA2B P08514 1/20 0.31
▸ PTGS2 P35354 1/20 0.31
▸ HDAC6 Q9UBN7 1/20 0.31
▸ AKR1B1 P15121 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ PDE4B Q07343 1/20 0.31
▸ CCNT1 O60563 2/20 0.31
▸ CDK9 P50750 2/20 0.31
▸ MAPK1 P28482 1/20 0.31
▸ FFAR4 Q5NUL3 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30937656 0.85 ACE (0.37) ACEMMP13KDM4EALDH1A1DDB1
SCHEMBL30937588 0.81 ACE (0.48) ACEMMP13KDM4EALDH1A1ITGB3
SCHEMBL30937708 0.75 GPR139 (0.43) ACEMMP13MAPK1
SCHEMBL30937681 0.70 ACE (0.42) ACEMMP13KDM4EALDH1A1LMNA
SCHEMBL30937524 0.69 ACE (0.44) ACEMMP13KDM4EALDH1A1LMNA
SCHEMBL30937651 0.69 ACE (0.53) ACEMMP13CDK5CDK5R1KDM4E
SCHEMBL30937608 0.69 ACE (0.42) ACEMMP13KDM4EALDH1A1PDE4B
SCHEMBL31120591 0.68 ACE (0.45) ACEMMP13KDM4EALDH1A1AKR1B1
SCHEMBL30937665 0.67 ACE (0.47) ACEMMP13KDM4EALDH1A1ITGB3
SCHEMBL30937679 0.65 BRD4 (0.51) ACEMMP13KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594307-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2025-08-06 — — EP disclosed
WO-2024073426-A1 1,4-DIHYDROQUINAZOLINONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. (US) 2024-04-04 — — WO disclosed
Send feedback